Other
Pathophysiology
0
Pipeline Programs↗
5
Active Trials↗
0
Companies Involved↗
Pathophysiology is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Completed6 · 50%
Recruiting3 · 25%
Active, not recruiting1 · 8%
Not yet recruiting1 · 8%
Withdrawn1 · 8%
Clinical Trials
Trial Activity
12 trials
TReatment for ImmUne Mediated PathopHysiology
Recruiting·National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·Phase 2·NCT04862221·163 enrolled
Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology
Active, not recruiting·—·Phase 2·NCT04451837·200 enrolled
Placental Organoids Development: Application in the Study of the Human Reproduction Pathophysiology.
Not yet recruiting·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·N/A·NCT06893978·20 enrolled
Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura
Completed·—·N/A·NCT02317133·100 enrolled
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
Completed·—·Phase 2·NCT03844412·209 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)